Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Prevention

CO2 Versus Lund De-airing Technique in Heart Surgery

Aortic Valve Disorder

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcome: Primary: Number of Air Microemboli Registered Over the Middle Cerebral Arteries by On-line Trans-cranial Echo-Doppler (TCD). — 41; 118 Air Microemboli — p=<0.01

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Lund de-airing technique (Procedure); carbon-dioxide insufflation (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Lund University
Primary completion
Oct 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Air Microemboli Registered Over the Middle Cerebral Arteries by On-line Trans-cranial Echo-Doppler (TCD).
5; 46 <0.001 sig
PRIMARY
Number of Air Microemboli Registered Over the Middle Cerebral Arteries by On-line Trans-cranial Echo-Doppler (TCD).
5; 46 <0.001 sig
PRIMARY
Number of Air Microemboli Registered Over the Middle Cerebral Arteries by On-line Trans-cranial Echo-Doppler (TCD).
5; 46 <0.001 sig
PRIMARY
Number of Participants With <=Grade I Gas Emboli as Assessed by Trans-esophageal Echocardiography TEE).
9; 7
PRIMARY
Number of Participants With <=Grade I Gas Emboli as Assessed by Trans-esophageal Echocardiography TEE).
9; 7
PRIMARY
Number of Participants With <=Grade I Gas Emboli as Assessed by Trans-esophageal Echocardiography TEE).
9; 7
SECONDARY
Total Time Required for De-airing
9; 15
SECONDARY
De-airing Time Before Cardiac Ejection
6; 7
SECONDARY
De-airing Time After Cardiac Ejection
3; 5
SECONDARY
Oxygenator Gas Flow at 45 Minutes of CPB
0.65; 2.2
SECONDARY
pH at 45 Min of CPB
7.30; 7.35

Summary

To evaluate which of the two de-airing methods (CO2 insufflation vs. Lund de-airing technique) can shorten the left heart de-airing time and prevent or minimize cerebral air emboli during open surgery involving exposure of the left heart to the ambient air. To evaluate the cost effectiveness and possible side effects of CO2 de-airing technique compared to Lund de-airing technique.

Eligibility Criteria

Inclusion Criteria

  • Patients planned for aortic valve/root replacement or repair will be selected for the study

Exclusion Criteria

Patients with known

  • chronic obstructive pulmonary disease,
  • emphysema,
  • previous thoracic or cardiac surgery,
  • history of CVA or stroke and
  • evidence of intraoperative pleural adhesions will be excluded from the study.
  • Patients requiring internal mammary artery coronary bypass will also be excluded.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00934596). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search